Buprenorphine is indicated for the substitution treatment of opioid drug dependence. According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD ...

Sanofi SNY announced that the phase III IRAKLIA study, which evaluated a fixed-dose subcutaneous (SC) formulation of its ...

格隆汇1月10日丨复星医药(02196.HK)公告，上海复星医药(集团)股份有限公司(以下简称“本公司”)控股子公司上海复宏汉霖生物技术股份有限公司及其控股子公司(以下合称“复宏汉霖”)于近日收到国家药品监督管理局(以下简称“国家药监局”)关于同意注 ...

RQ Bio welcomes positive CHMP opinion on Kavigale for prevention of COVID-19 in immunocompromised individuals Kavigale ...

New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma. Sarclisa SC formulation added to Pd for the treatment of R/R MM me ...

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.

周二，加拿大皇家银行资本市场调整了对百健 (Biogen)股票的展望，分析师Brian Abrahams将目标价从之前的260美元下调至231美元。尽管如此，该公司仍维持对这家生物科技公司股票的"优于大盘"评级，目前该股交易价格为153.27美元。根据 InvestingPro 数据，该股目前接近52周低点，市值为223亿美元。

周二，RBC Capital Markets调整了Apellis Pharmaceuticals (NASDAQ:APLS)的股票目标价，将其从之前的24.00美元上调至26.00美元，同时维持对该公司股票的板块表现评级。过去一周，该股表现强劲，上涨7.74%，交易价格为34.38美元。

SC AG (4SC, FSE Prime Standard: VSC), a biotech company improving the lives of patients suffering with advanced-stage cutaneous T-cell lymphoma (CTCL), today announced that it had submitted its ...

Shares of Geron Corp. decreased by 3.92 percent on Monday to finish the day at $3.43 apiece as investors remained on the ...